From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma

Immunotherapy has revolutionized the treatment landscape for many cancer types. The treatment for renal cell carcinoma (RCC) has especially evolved in recent years, from cytokine-based immunotherapies to immune checkpoint inhibitors. Although clinical benefit from immunotherapy is limited to a subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Anker, Jonathan, Miller, Justin, Taylor, Nicole, Kyprianou, Natasha, Tsao, Che-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619121/
https://www.ncbi.nlm.nih.gov/pubmed/34831452
http://dx.doi.org/10.3390/cells10113231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619121/
https://www.ncbi.nlm.nih.gov/pubmed/34831452
http://dx.doi.org/10.3390/cells10113231

Ejemplares similares